<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03465475</url>
  </required_header>
  <id_info>
    <org_study_id>Inonu uni</org_study_id>
    <nct_id>NCT03465475</nct_id>
  </id_info>
  <brief_title>Anesthetic Cost Analysis With Desflurane in Automated Gas Control Mode</brief_title>
  <official_title>Anesthetic Cost Analysis With Desflurane in Automated Gas Control Mode With Maquet Flow-i Anaesthesia Machine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inhalation agents constitute the major part of anesthetic drug costs (20% - 25%) and a&#xD;
      significant portion of the applied inhalation agents are thrown into the atmosphere through&#xD;
      the waste gas system without being absorbed by the patient. The amount of waste gas is&#xD;
      directly correlated to the fresh gas flow (FGF). Reducing the TGA during general anesthesia&#xD;
      reduces the consumption of inhalant agents and contributes to the reduction of greenhouse gas&#xD;
      pollution. Risks such as hypoxia, hypercapnia, inadequate depth of anesthesia and potential&#xD;
      toxic gas accumulation were associated with low flow anesthesia, but the patient was provided&#xD;
      with adequate safety by following pulse oximetry, capnography, FiO2 and anesthetic gas&#xD;
      analysis. We aimed to perform anesthetic cost analysis and patient security in automated gas&#xD;
      control mode (AGC).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the ethical approvel 60 adult patients scheduled for hepatectomy will be taken to&#xD;
      study. Patients will be monitored after they are taken to the operating room (ECG, NIBP,&#xD;
      SpO2, Body Temp, BIS, NIRS, PVI, PI, ORI). After the anesthesia induction and tarakeal&#xD;
      entubation, first twenty patient will take 300 mL fresh gas flow with AGC mode (group 1),&#xD;
      Second twenty patient will take 600 mL fresh gas flow with AGC mode (group 2), third twenty&#xD;
      patient will take 600 mL fresh gas flow with manually. Hemodynamic and gas consumption data&#xD;
      will be recorded. An operating room will be reserved for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of used anesthetic gas (desflurane)</measure>
    <time_frame>Through study completion, an average of 2 month</time_frame>
    <description>Amount of used desflurane will be determined in milliliter by anesthesia machine (Maquet Flow i40) for each patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Through study completion, an average of 2 month</time_frame>
    <description>Heart rate/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>Through study completion, an average of 2 month</time_frame>
    <description>Mean arterial pressure (mm/Hg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral oxygen saturation</measure>
    <time_frame>Through study completion, an average of 2 month</time_frame>
    <description>Peripheral oxygen saturation (%)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Safety Issues</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>The patient who receive 300 mL fresh gas flow with AGC mode during the general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>The patient who receive 600 mL fresh gas flow with AGC mode during the general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>The patient who receive 600 mL fresh gas flow with manuelly during the general anesthesia</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing hepatectomy operation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing hepatectomy with general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Essential data missing&#xD;
&#xD;
          -  Patient participating in other research projects&#xD;
&#xD;
          -  Drug allergy&#xD;
&#xD;
          -  Anesthetic complication story&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yusuf Z Çolak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inonu Univercity</name>
      <address>
        <city>Malatya</city>
        <zip>44280</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Yusuf Ziya ÇOLAK</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Low flow anesthesia</keyword>
  <keyword>Desflurane</keyword>
  <keyword>Cost analysis</keyword>
  <keyword>Automated gas control</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

